IT Tech Packaging Inc Dossier
|
SectorMaterials IndustryPaper & Forest Products Beta (adjusted)0.18 Intrinsic Value No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference. Market Price $0.15Price as of 1 Oct 2026 Data confidence Sign in to view data confidence Market Cap $2.5M Enterprise Value $1.7M Shares Outstanding 17M diluted Last ex-dividend26 Nov 2013 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary IT Tech Packaging, Inc. (ITP) is facing severe operational, financial, and regulatory distress. The company has failed to file its Form 10-K for the fiscal year ended December 31, 2025, and its Form 10-Q for the period ended March 31, 2026, triggering a non-compliance notice from the NYSE American. Operationally, the company is highly unprofitable, posting a net loss of $1.45 million for Q3 2025 and a total net loss of $6.9 million for the first nine months of 2025. Management has disclosed substantial doubt about the company's ability to continue as a going concern due to suspended production at its Tengsheng Paper segment, soft demand, high depreciation, and elevated raw material costs. Given the high risk of delisting and potential bankruptcy, a Strong Sell recommendation is warranted. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario The NYSE American truncates the cure period and immediately commences delisting procedures due to the severity of the filing delinquencies and going concern issues. Creditors demand immediate repayment of outstanding debts, leading to an abrupt insolvency event. Base CaseCentral scenario The company fails to file its delinquent financial reports within the NYSE American's cure period, leading to suspension and eventual delisting of its common stock. Operational losses continue to widen as domestic demand in China remains soft and raw material costs remain elevated, ultimately forcing the company into restructuring or liquidation. Bull CaseUpside scenario The company successfully files its delinquent Form 10-K and Form 10-Q reports, fully restoring compliance with NYSE American listing standards and removing the delisting overhang. Concurrently, a recovery in domestic Chinese demand for corrugating medium paper (CMP) combined with successful commercialization of the PM10 tissue paper line drives a return to positive gross margins and net profitability. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |